|
Sample | Upregulated | Related mechanism | Publication |
|
Serum and urine | miR-429 | IRS-1: a target gene of miR-429 | [57] |
Serum | miR-1323 | Inhibit trophoblast cell viability via inhibiting TP53INP1 | [58] |
Serum | miR-16-5p, miR-29a-3p, and miR-134-5p | — | [59] |
Placenta | miR-222 | Suppress inflammatory response by promoting CXCR4 and inactivating NLRP3 inflammasomes | [60] |
Serum | miR-2467 | Adiponectin: a target gene of miR-2467 | [61] |
Placenta | miR-140-3p | Relate to defective placental IR signaling | [62] |
Blood | miRNA-223 | — | [63] |
Serum | miR-195-5p | Inhibit cell viability and proliferation and promote apoptosis by targeting EZH2 | [64] |
Blood | miR-330-3p | INS-1 cell dysfunction | [65] |
Peripheral blood | miR-770-5p | Influence pancreatic β-cell function | [66] |
Placental macrophages | miR-657 | Regulate macrophage proliferation, migration and polarization | [67] |
Serum | miRNA-19a and miRNA-19b | — | [68] |
Placenta-derived mononuclear macrophages | miR-657 | Influence inflammatory response via IL-37/NF-κB signaling axis | [69] |
Plasma | miR-137 | HG-induced VEC dysfunction | [70] |
Whole blood cells | miRNA-340 | PAIP1: a miRNA-340 target gene | [71] |
Placenta tissue | miR-503 | Regulate pancreatic β-cell function by targeting the mTOR pathway | [72] |
Plasma | miR-16-5p, miR-17-5p, and miR-20a-5p | Correlate with IR | [35] |
Placenta | miR-98 | Link to the global DNA methylation by targeting Mecp2 | [73] |
HUVECs | circ_0074673 | Regulate the proliferation, migration and angiogenesis of HG-HUVECs via the miR-1200/MEOX2 axis | [74] |
Plasma | circ_0008285 | circ_0008285 may maintain the HTR-8/SVneo trophoblast cell function by the PI3K/Akt signaling pathway | [45] |
Placental tissues | Circ-PNPT1 | Promoted HG-induced trophoblast cell biological dysfunction through miR-889-3p/PAK1 axis | [52] |
Peripheral blood | ERMP1, TSPAN32, MRPL38, and RPL13P5 | RPL13P5 involved in insulin resistance via the PI3K-AKT and insulin signaling pathways | [75] |
Umbilical cord blood exosomes | Lnc-RXYLT1-3 : 2, lnc-TFDP2-7 : 2, lncCOX17-2 : 3, and lnc-ZBTB46-3 : 6 | Most of the exosomal lncRNAs harbored miRNA binding sites | [16] |
Plasma | MEG8 | — | [76] |
Placental tissues | MALAT1 | Associate with inflammation and the proliferation, invasion, and migration of placental trophoblastic cells via modulating the TGF-β/NF-κB signaling pathway | [77] |
Blood and placental villous tissues | MEG3 | miR-345-3p: a target; inhibit HTR-8/SVneo cell viability, and prevent cell migration and invasion in addition to inducing cell apoptosis | [78] |
Serum | MALAT1 | — | [79] |
Plasma | SOX2OT | — | [80] |
|